静脈注射用の溶液の世界市場分析:タイプ別(全非経口栄養(TPN)、末梢非経口栄養(PPN))、栄養素(炭水化物、非経口脂質エマルジョン、単一用量アミノ酸溶液、ビタミン&ミネラル(塩および電解質))、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Intravenous (IV) Solutions Market Analysis by Type [Total Parenteral Nutrition (TPN), Peripheral Parenteral Nutrition (PPN)], Nutrients (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Vitamins & Minerals (Salt and electrolyte)) And Segment Forecasts to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
Chapter 2 Executive Summary
Chapter 3 IV Solutions Industry Outlook
3.1 Market Segmentation
3.2 Market Size and Growth Prospects, 2013 – 2024
3.3 IV Solutions Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing natality rate
3.3.1.2 Rising number of premature births
3.3.1.3 Risk of malnutrition
3.3.1.4 Rising geriatric population base
3.3.1.5 Increasing incidence of cancer
3.3.2 Market restraint analysis
3.3.2.1 Shortage of parenteral nutrition products
3.3.2.2 Increased use of enteral nutrition
3.3.2.3 High risk of infection
3.3.2.4 Stringent regulations
3.4 Key Opportunities Prioritized
3.5 Clinical nutrition market: 2014 (E) percentage market share of major companies
3.6 Intravenous solution products market: 2013 percentage market share of major companies
3.7 Competition analysis (Strategic Initiatives)
3.8 Industry Analysis – Porter’s
3.9 IV Solutions PESTEL Analysis
3.10 Product technology/Research
Chapter 4 Market Categorization 1: Type Estimates & Trend Analysis
4.1 Global IV Solutions Market: Type Movement Analysis
4.2 Total Parenteral Nutrition Market (TPN)
4.2.1 Total Parenteral Nutrition Market (TPN) market estimates and forecasts, 2013 – 2024 (USD Million)
4.3 Peripheral Parenteral Nutrition (PPN)
4.3.1 Peripheral Parenteral Nutrition (PPN) market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 5 Market Categorization 2: Nutrient Estimates & Trend Analysis
5.1 Nutrient Movement Analysis & Market Share, 2015 & 2024
5.2 Carbohydrates
5.2.1 Carbohydrates market estimates and forecasts, 2013 – 2024 (USD Million)
5.3 Single dose amino acid solution
5.3.1 Single dose amino acid solution market estimates and forecasts, 2013 – 2024 (USD Million)
5.4 Vitamins & minerals (salt and electrolyte)
5.4.1 Vitamins & minerals (salt and electrolyte) market estimates and forecasts, 2013 – 2024 (USD Million)
5.5 Parenteral lipid emulsion
5.5.1 Parenteral lipid emulsion market estimates and forecasts, 2013 – 2024 (USD Million)
5.6 Others (trace elements)
5.6.1 Others (trace elements) market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization 3: Regional Estimates & Trend Analysis, by Type & Nutrient
6.1 Regional Movement Analysis & Market Share, 2015 & 2024
6.2 North America
6.2.1 North America IV solutions market, by type, 2013 – 2024 (USD Million)
6.2.2 North America IV solutions market, by nutrient, 2013 – 2024 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. IV solutions market, by type, 2013 – 2024 (USD Million)
6.2.3.2 U.S. IV solutions market, by nutrient, 2013 – 2024 (USD Million)
6.2.4 Canada
6.2.4.1 Canada IV solutions market, by type, 2013 – 2024 (USD Million)
6.2.4.2 Canada IV solutions market, by nutrient, 2013 – 2024 (USD Million)
6.3 Europe
6.3.1 Europe IV solutions market, by type, 2013 – 2024 (USD Million)
6.3.2 Europe IV solutions market, by nutrient, 2013 – 2024 (USD Million
6.3.3 Germany
6.3.3.1 Germany IV solutions market, by type, 2013 – 2024 (USD Million)
6.3.3.2 Germany IV solutions market, by nutrient, 2013 – 2024 (USD Million)
6.3.4 UK
6.3.4.1 UK IV solutions market, by type, 2013 – 2024 (USD Million)
6.3.4.2 UK IV solutions market, by nutrient, 2013 – 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific IV Solutions market, by type, 2013 – 2024 (USD Million)
6.4.2 Asia Pacific IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.4.3 Japan
6.4.3.1 Japan IV Solutions market, by type, 2013 – 2024 (USD Million)
6.4.3.2 Japan IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.4.4 China
6.4.4.1 China IV Solutions market, by type, 2013 – 2024 (USD Million)
6.4.4.2 China IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.4.5 India
6.4.5.1 India IV Solutions market, by type, 2013 – 2024 (USD Million)
6.4.5.2 India IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.4.6 Australia
6.4.6.1 Australia IV Solutions market, by type, 2013 – 2024 (USD Million)
6.4.6.2 Australia IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America IV Solutions market, by type, 2013 – 2024 (USD Million)
6.5.2 Latin America IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil IV Solutions market, by type, 2013 – 2024 (USD Million)
6.5.3.2 Brazil IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico IV Solutions market, by type, 2013 – 2024 (USD Million)
6.5.4.2 Mexico IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.6 MEA
6.6.1 MEA IV Solutions market, by type, 2013 – 2024 (USD Million)
6.6.2 MEA IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa IV Solutions market, by type, 2013 – 2024 (USD Million)
6.6.3.2 South Africa IV Solutions market, by nutrient, 2013 – 2024 (USD Million)
Chapter7 Competitive Landscape
7.1 Fresenius Kabi
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Sino-Swed Pharmaceutical Corp., Ltd.
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Hospira
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Amanta Healthcare
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Otsuka Pharmaceutical Co., Ltd.
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Sichuan Kelun Pharmaceutical Co., Ltd.
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic Initiatives
7.7 Terumo Corporation
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Baxter
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 B. Braun Melsungen AG
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 Claris Lifesciences Ltd.
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
7.11 Kyowa Hakko Bio Co., Ltd.
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic initiatives
7.12 Grifols
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic initiatives
7.13 Liqvor Pharmaceuticals
7.13.1 Company overview
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic initiatives


【レポート販売概要】

■ タイトル:静脈注射用の溶液の世界市場分析:タイプ別(全非経口栄養(TPN)、末梢非経口栄養(PPN))、栄養素(炭水化物、非経口脂質エマルジョン、単一用量アミノ酸溶液、ビタミン&ミネラル(塩および電解質))、セグメント予測
■ 英文:Intravenous (IV) Solutions Market Analysis by Type [Total Parenteral Nutrition (TPN), Peripheral Parenteral Nutrition (PPN)], Nutrients (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Vitamins & Minerals (Salt and electrolyte)) And Segment Forecasts to 2024
■ 発行日:2016年10月3日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707453
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。